Stocks
Sarepta Therapeutics, Inc.SRPT
NASDAQHealthcareBiotechnology$20.52-3.76%
Price as of · delayed, not real-time
Focused on precision genetic medicine, this biopharmaceutical company develops RNA-targeted therapeutics for rare diseases. Investors track its pipeline of exon-skipping therapies for Duchenne muscular dystrophy and other neuromuscular conditions.
Market Cap: $1.7B52W Range: $14.68-$25.32
Congressional Interest in Sarepta Therapeutics, Inc. (SRPT)
6 members of Congress have disclosed 22 trades in Sarepta Therapeutics, Inc. (SRPT), a Healthcare company. The buy/sell breakdown shows 13 purchases versus 9 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
22
Unique Politicians
6
Buys
13
Sells
9
Who in Congress Is Trading SRPT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-04-14 | Gilbert Cisneros | sell | $1K-$15K |
| 2024-11-19 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2024-11-12 | Rohit Khanna | sell | $1K-$15K |
| 2023-07-14 | Josh Gottheimer | buy | $1K-$15K |
| 2023-06-13 | Josh Gottheimer | sell | $1K-$15K |
| 2023-04-10 | Daniel Goldman | sell | $15K-$50K |
| 2023-03-06 | Daniel Goldman | buy | $15K-$50K |
| 2023-03-06 | Josh Gottheimer | buy | $1K-$15K |
| 2023-01-31 | Daniel Goldman | sell | $1K-$15K |
| 2022-12-14 | MICHAEL T. MCCAUL | sell | $15K-$50K |
| 2020-11-06 | Josh Gottheimer | sell | $1K-$15K |
| 2020-09-14 | Gilbert Cisneros | buy | $1K-$15K |
| 2020-06-10 | Gilbert Cisneros | sell | $1K-$15K |
| 2019-12-13 | Josh Gottheimer | buy | $1K-$15K |
| 2019-10-11 | Gilbert Cisneros | buy | $1K-$15K |
| 2019-10-10 | Gilbert Cisneros | buy | $1K-$15K |
| 2019-04-09 | Gilbert Cisneros | buy | $1K-$15K |
| 2019-03-11 | Gilbert Cisneros | buy | $1K-$15K |
| 2019-02-27 | Gilbert Cisneros | buy | $1K-$15K |
| 2019-02-26 | Gilbert Cisneros | buy | $1K-$15K |
| 2017-09-19 | JAMES B. RENACCI | buy | $15K-$50K |
| 2015-03-30 | MICHAEL T. MCCAUL | buy | $1K-$15K |